
© 2024 Der Aktionär
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Pfizer Crosses Above 7% Yield Territory | ||
Di | Pfizer RSV shot approved in EU for adults aged 18 - 59 | ||
Di | Pfizer, Flagship tap Valo Health for autoimmune offshoot of multibillion-dollar collab | ||
Di | Pfizer's RSV vaccine receives EC approval for individuals aged 18 to 59 years | ||
Di | Pfizer's RSV vaccine wins expanded approval in EU, gaining edge over GSK |